World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
90
Citations
37022
World Ranking
2400
National Ranking
52

Overview

Jean-Marc Herbert is affiliated with the Centre national de la recherche scientifique (CNRS) in France. The research conducted by this scientist is primarily situated within the fields of Immunology and Microbiology, with a particular focus on Immunology and Pharmacology as subfields.

The scientist's work addresses topics related to Phagocytosis and Immune Regulation, the Complement system in diseases, and Apelin-related biomedical research. These themes indicate a concentration on immune system mechanisms and their implications in disease contexts.

Jean-Marc Herbert has contributed to several publications, including peer-reviewed articles published in recognized venues. Notable recent papers include:

  • Author Correction: Conversion of human fibroblasts to angioblast-like progenitor cells, 2020, Nature Methods
  • Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy, 2020, UNC Libraries

Collaboration appears as a significant aspect of their research activity, with frequent co-authors as follows:

  • Leo Kurian
  • Ignacio Sancho-Martinez
  • Emmanuel Nivet
  • Aitor Aguirre
  • Krystal Moon

Jean-Marc Herbert's frequent publication venues include:

  • Nature Methods
  • UNC Libraries

Best Publications

  • Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.

    Peter Carmeliet;Yuval Dor;Jean-Marc Herbert;Dai Fukumura

  • Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

    Peter Carmeliet;Lieve Moons;Aernout Luttun;Valeria Vincenti

  • Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis.

    Peter Carmeliet;Maria Grazia Lampugnani;Lieve Moons;Ferrucio Breviario

  • Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

    Aernout Luttun;Marc Tjwa;Lieve Moons;Yan Wu

  • Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

    B. Oosthuyse;L. Moons;E. Storkebaum;H. Beck

  • Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

    Monica Autiero;Johannes Waltenberger;Didier Communi;Andrea Kranz

  • Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.

    Stephane Heymans;Aernout Luttun;Dieter Nuyens;G Theilmeier

  • Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

    Michèle Guerre-Millo;Philippe Gervois;Eric Raspé;Lise Madsen

  • Structure and stereochemistry of the active metabolite of clopidogrel

    Jean-Marie Pereillo;Mohamed Maftouh;Alain Andrieu;Marie-Francoise Uzabiaga

  • Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis.

    Anne Angelillo-Scherrer;Pablo Garcia de Frutos;Cristina Aparicio;Els Melis

  • The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways.

    Edward Conway;Marlies Lutgart Julien Van de Wouwer;Saskia Pollefeyt;Kerstin Jurk

  • Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis

    Pierre Savi;Jean-Marc Herbert

  • Synthesis of thrombin-inhibiting heparin mimetics without side effects

    Maurice Petitou;Jean-Pascal Hérault;André Bernat;Pierre-Alexandre Driguez

  • Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.

    Magali Gary-Bobo;Ghizlane Elachouri;Jean François Gallas;Philip Janiak

  • The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts

    Pierre Savi;Jean-Luc Zachayus;Nathalie Delesque-Touchard;Catherine Labouret

  • The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A.

    Savi P;Combalbert J;Gaich C;Rouchon Mc

  • Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration.

    Benoit Favier;Antoine Alam;Pauline Barron;Jacques Bonnin

  • Specific Impairment of Human Platelet P2YAC ADP Receptor–Mediated Signaling by the Antiplatelet Drug Clopidogrel

    J. Geiger;J. Brich;P. Hönig-Liedl;M. Eigenthaler

  • P2y(12), a new platelet ADP receptor, target of clopidogrel.

    P. Savi;C. Labouret;N. Delesque;F. Guette

  • VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis

    Fan Zhang;Zhongshu Tang;Xu Hou;Johan Lennartsson

Frequent Co-Authors

Desire Collen
Desire Collen KU Leuven
Lieve Moons
Lieve Moons KU Leuven
Maurice Petitou
Maurice Petitou University of Cambridge
Florea Lupu
Florea Lupu Oklahoma Medical Research Foundation
Pierre Sinaÿ
Pierre Sinaÿ École Normale Supérieure
Jean-Pierre Cazenave
Jean-Pierre Cazenave University of Strasbourg
Yuval Dor
Yuval Dor Hebrew University of Jerusalem
Rakesh K. Jain
Rakesh K. Jain Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Jean-Marc Herbert

Trending Scientists